Published 6 October 2003. doi:10.1084/jem.20030698
© Rockefeller University Press,
0022-1007/2003/10/1103 $5.00
The Journal of Experimental Medicine, Volume 198, Number 7, 1103-1106
Effective Destruction of Fas-deficient Insulin-producing ß Cells in Type 1 Diabetes
Irina Apostolou1,
Zhenyue Hao2,
Klaus Rajewsky3 and
Harald von Boehmer1
1 Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115
2 Advanced Medical Discovery Institute, Toronto, Ontario M5G 2C1, Canada
3 Harvard Medical School, Center for Blood Research, Boston, MA 02115
Address correspondence to Harald von Boehmer, Harvard Medical School, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, Phone: (617) 632-6882; Fax: (617) 632-6881; e-mail: Harald_von_Boehmer{at}dfci.harvard.edu
In type 1 diabetes, autoimmune T cells cause destruction of pancreatic ß cells by largely unknown mechanism. Previous analyses have shown that ß cell destruction is delayed but can occur in perforin-deficient nonobese diabetic (NOD) mice and that Fas-deficient NOD mice do not develop diabetes. However, because of possible pleiotropic functions of Fas, it was not clear whether the Fas receptor was an essential mediator of ß cell death in type 1 diabetes. To directly test this hypothesis, we have generated a ß cellspecific knockout of the Fas gene in a transgenic model of type 1 autoimmune diabetes in which CD4+ T cells with a transgenic TCR specific for influenza hemagglutinin (HA) are causing diabetes in mice that express HA under control of the rat insulin promoter. Here we show that the Fas-deficient mice develop autoimmune diabetes with slightly accelerated kinetics indicating that Fas-dependent apoptosis of ß cells is a dispensable mode of cell death in this disease.
Key Words: Fas receptor diabetes ß cell death autoimmunity conditional knockout

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Ishimaru, N., Arakaki, R., Yoshida, S., Yamada, A., Noji, S., Hayashi, Y.
(2008). Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. JEM
205: 2915-2927
[Abstract]
[Full Text]
-
Mohamood, A. S., Guler, M. L., Xiao, Z., Zheng, D., Hess, A., Wang, Y., Yagita, H., Schneck, J. P., Hamad, A. R. A.
(2007). Protection from Autoimmune Diabetes and T-Cell Lymphoproliferation Induced by FasL Mutation Are Differentially Regulated and Can Be Uncoupled Pharmacologically. Am. J. Pathol.
171: 97-106
[Abstract]
[Full Text]
-
Dudek, N. L., Thomas, H. E., Mariana, L., Sutherland, R. M., Allison, J., Estella, E., Angstetra, E., Trapani, J. A., Santamaria, P., Lew, A. M., Kay, T. W.H.
(2006). Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy {beta}-Cells via the Perforin and Fas Pathways. Diabetes
55: 2412-2418
[Abstract]
[Full Text]
-
Mohamood, A. S., Trujillo, C. J., Zheng, D., Jie, C., Murillo, F. M., Schneck, J. P., Hamad, A. R. A.
(2006). Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells. Int Immunol
18: 1265-1277
[Abstract]
[Full Text]
-
McKenzie, M. D, Dudek, N. L, Mariana, L., Chong, M. M., Trapani, J. A, Kay, T. W., Thomas, H. E
(2006). Perforin and Fas induced by IFN{gamma} and TNF{alpha} mediate beta cell death by OT-I CTL. Int Immunol
18: 837-846
[Abstract]
[Full Text]
-
Ishimaru, N., Arakaki, R., Omotehara, F., Yamada, K., Mishima, K., Saito, I., Hayashi, Y.
(2006). Novel Role for RbAp48 in Tissue-Specific, Estrogen Deficiency-Dependent Apoptosis in the Exocrine Glands. Mol. Cell. Biol.
26: 2924-2935
[Abstract]
[Full Text]
-
Allison, J., Thomas, H. E., Catterall, T., Kay, T. W. H., Strasser, A.
(2005). Transgenic Expression of Dominant-Negative Fas-Associated Death Domain Protein in {beta} Cells Protects against Fas Ligand-Induced Apoptosis and Reduces Spontaneous Diabetes in Nonobese Diabetic Mice. J. Immunol.
175: 293-301
[Abstract]
[Full Text]
-
Vence, L., Benoist, C., Mathis, D.
(2004). Fas Deficiency Prevents Type 1 Diabetes by Inducing Hyporesponsiveness in Islet {beta}-Cell-Reactive T-Cells. Diabetes
53: 2797-2803
[Abstract]
[Full Text]
-
Zeng, W., Chen, G., Kajigaya, S., Nunez, O., Charrow, A., Billings, E. M., Young, N. S.
(2004). Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. Blood
103: 325-332
[Abstract]
[Full Text]